| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AICAR | GDSC1000 | pan-cancer | AAC | -0.089 | 0.005 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.005 |
| mRNA | GSK1070916 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.005 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | -0.094 | 0.006 |
| mRNA | WZ8040 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | navitoclax:pluripotin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.097 | 0.006 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | -0.13 | 0.008 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.19 | 0.009 |